Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structures

Pharmaceutical Development and Technology

Volumn 22, Issue 3, 2017, Pages 350-359

  Opanasopit, Praneet ^a   Leksantikul, Lalita ^a   Niyomtham, Nattisa ^b   Rojanarata, Theerasak ^a   Ngawhirunpat, Tanasait ^a   Yingyongnarongkul, Boon Ek ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b RAMKHAMHAENG UNIVERSITY   (Thailand)

Author keywords

Cationic niosomes; central core structures; gene transfection; spermine derivatives

Indexed keywords

CHOLESTEROL; GREEN FLUORESCENT PROTEIN; NIOSOME; NONIONIC SURFACTANT; SORBITAN LAURATE; SPERMINE DERIVATIVE; CATION; DNA; DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; SPERMINE;

ARTICLE; CELL VIABILITY; CHEMICAL STRUCTURE; COMPLEX FORMATION; FEMALE; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; BLOOD; CELL SURVIVAL; CHEMISTRY; GENE TRANSFER; GENETICS; PLASMID; SURFACE PROPERTY;

CATIONS; CELL SURVIVAL; DNA; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LIPIDS; LIPOSOMES; PARTICLE SIZE; PLASMIDS; SPERMINE; SURFACE PROPERTIES; TRANSFECTION;

EID: 84951870451     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2015.1125925     Document Type: Article

References (28)

1. Misra S., Human gene therapy:a brief overview of the genetic revolution. J Assoc Physicians India 2013;61:127–133
2. Gabor MR., The future of human gene therapy. Mol Aspects Med 2001;22:113–142
3. Tros de Ilarduya C, Sun Y, Düzgüneş N., Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 2010;40:159–171
4. Serikawa T, Suzuki N, Kikuchi H, et al. A new cationic liposome for efficient gene delivery with serum into cultured human cells:a quantitative analysis using two independent fluorescent probes. Biochim Biophys Acta 2000;1467:419–430
5. Huang Y, Chen J, Chen X, et al. PEGylated synthetic surfactant vesicles (Niosomes):novel carriers for oligonucleotides. J Mater Sci 2008;19:607–614
6. Manosroi A, Thathang K, Werner RG, et al. Stability of luciferase plasmid entrapped in cationic bilayer vesicles. Int J Pharm 2008;356:291–299
7. Paecharoenchai O, Niyomtham N, Ngawhirunpat T, et al. Cationic niosomes composed of spermine-based cationic lipids mediate high gene transfection efficiency. J Drug Target 2012;20:783–792
8. Paecharoenchai O, Teng L, Yung BC, et al. Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine 2013;8:1865–1873
9. Paecharoenchai O, Niyomtham N, Leksantikul L, et al. Nonionic surfactant vesicles composed of novel spermine-derivative cationic lipids as an effective gene carrier in vitro. AAPS PharmSciTech 2014;15:722–730
10. Pardakhty A, Moazeni E., Nano-niosomes in drug, vaccine and gene delivery:a rapid overview. Nanomedicine J 2013;1:1–12
11. Marianecci C, Di Marzio L, Rinaldi F, et al. Niosomes from 80s to present:the state of the art. Adv Colloid Interface 2014;205:187–206
12. Moghassemi S, Hadjizadeh A., Nano-niosomes as nanoscale drug delivery systems:an illustrated review. J Control Rel 2014;185:22–36
13. Abdelkader H, Alani AW, Alany RG., Recent advances in non-ionic surfactant vesicles (niosomes):self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 2014;21:87–100
14. Fang JY, Hong CT, Chiu WT, Wang YY., Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001;219:61–72
15. Tavano L, Vivacqua M, Carito V, et al. Doxorubicin loaded magneto-niosomes for targeted drug delivery. Colloids Surf B Biointerfaces 2013;102:803–807
16. Huang Y, Rao Y, Chen J, et al. Polysorbate cationic synthetic vesicle for gene delivery. J Biomed Mater Res A 2011;96:513–519
17. Khositsuntiwong N, Manosroi A, Götz F, et al. Enhancement of gene expression and melanin production of human tyrosinase gene loaded in elastic cationic niosomes. J Pharm Pharmacol 2012;64:1376–1385
18. Ram IM., Water insoluble and soluble lipids for gene delivery. Adv Drug Deliv Rev 2005;57:699–712
19. Morille M, Passirani C, Vonarbourg A, et al. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008;29:3477–3496
20. Niyomtham N, Apiratikul N, Suksen K, et al. Synthesis and in vitro transfection efficiency of spermine-based cationic lipids with different central core structures and lipophilic tails. Bioorg Med Chem Lett 2015;25:496–503
21. Peng J, He X, Wang K, et al. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Nanomedicine 2006;2:113–120
22. Karni M, Zidon D, Polak P, et al. Thermal degradation of DNA. DNA Cell Biol 2013;32:298–301
23. Chen JL, Wang H, Gao JQ, et al. Liposomes modified with polycation used for gene delivery:preparation, characterization and transfection in vitro. Int J Pharm 2007;343:255–261
24. Weecharangsan W, Opanasopit P, Ngawhirunpat T, et al. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm 2008;348:161–168
25. Sato T, Ishii T, Okahata Y., In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001;22:2075–2080
26. Li S, Tseng WC, Stolz DB, et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum:implications for intravenous lipofection. Gene Ther 1999;6:585–594
27. Lu H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Rel 2006;114:100–109
28. He CX, Tabata Y, Gao JQ., Non-viral gene delivery carrier and its three-dimensional transfection system. Int J Pharm 2010;386:232–242